Demonstrates memory effects and inflammation thresholds in autism spectrum disorder, suggesting new therapeutic strategies.
Conventional models of the microbiota-gut-brain axis (MGBA) in Autism Spectrum Disorder (ASD) overlook the long-range memory effects inherent to neuroinflammation and gut dysbiosis, leading to underestimation of symptom persistence. This study introduces a bidirectional fractional-order dynamical system with compartment-specific fractional orders \(α _i ∈ (0,1]\) to capture these memory-dependent dynamics across five interconnected compartments: dietary antigens, gut dysbiosis, gut inflammation, neuroinflammation, and behavioral symptoms. We establish existence, uniqueness, boundedness, and stability via Matignon’s criterion, derive a novel inflammation threshold parameter \(R_0\) , prove a transcritical bifurcation at \(R_0=1\) , perform global Sobol sensitivity analysis, and formulate a fractional optimal control problem with three realistic interventions. Principal findings reveal: (i) a transcritical bifurcation at \(R_0=1\) separating healthy recovery from chronic pathology; (ii) sensitivity analysis identifies the microbiota recovery rate \(δ _m\) (elasticity \(-1.667\) ) as the most potent target for preventing chronicity and the behavioral recovery rate \(δ _b\) ( \(S_i = 0.285\) ) as the dominant driver of steady-state symptom severity; (iii) optimal control simulations demonstrate that triple combination therapy outperforms all double combinations, with direct behavioral intervention ( \(u_3\) ) essential for minimizing symptoms; and (iv) stronger memory effects (lower \(α\) ) significantly delay therapeutic recovery, confirming that ignoring memory fundamentally underestimates ASD symptom persistence.
No takes yet. Share an insight, caveat, or question.
Qahiti et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: